Release Date: 04/03/09 15:42 Summary: Appendix 3B - Expiry of Unlisted Options Price Sensitive: No Download Document 236.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%